Shanghai INT Medical Instruments Co., Ltd. (HKG: 1501)

Shanghai INT Medical Instruments Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	805.39	752.84	585.88	464.68	358.43	286.46
Revenue Growth (YoY)	14.99%	28.50%	26.08%	29.64%	25.12%	41.07%
Cost of Revenue	320.91	314.77	253.4	188.93	124.01	112.02
Gross Profit	484.49	438.07	332.49	275.75	234.42	174.44
Selling, General & Admin	186.24	166.82	120.68	79.07	57.44	58.13
Research & Development	132.01	125.85	99.63	89.96	64.59	30.76
Other Operating Expenses	-20.69	-19.08	-18.1	-38.49	-12.97	-8.11
Operating Expenses	297.79	274	203.14	131.11	109.07	80.77
Operating Income	186.7	164.07	129.34	144.64	125.35	93.67
Interest Expense	-3.02	-3.19	-0.82	-0.63	-0.09	-1.83
Interest & Investment Income	9.8	11.83	13.41	14.53	24.1	9.95
Currency Exchange Gain (Loss)	0.37	2.42	2.54	-2.84	-12.31	5.77
EBT Excluding Unusual Items	193.85	175.13	144.47	155.69	137.04	107.57
Gain (Loss) on Sale of Investments	3.61	-	-	-	-	4.35
Asset Writedown	-	-	-	-	0.04	-
Pretax Income	197.46	175.13	144.47	155.69	137.09	111.91
Income Tax Expense	25.56	21.9	10.64	15.25	20.57	15.38
Earnings From Continuing Operations	171.9	153.23	133.83	140.45	116.52	96.54
Minority Interest in Earnings	4.59	3.23	-2.12	2.52	4.84	3.08
Net Income	176.49	156.46	131.71	142.96	121.35	99.61
Preferred Dividends & Other Adjustments	9.31	4.58	1.57	-	-	-
Net Income to Common	167.18	151.88	130.15	142.96	121.35	99.61
Net Income Growth	9.37%	18.79%	-7.87%	17.80%	21.82%	70.42%
Shares Outstanding (Basic)	165	166	166	166	166	127
Shares Outstanding (Diluted)	169	171	169	167	166	127
Shares Change (YoY)	-0.79%	1.10%	1.32%	0.48%	31.04%	47.01%
EPS (Basic)	1.01	0.92	0.78	0.86	0.73	0.79
EPS (Diluted)	1.01	0.92	0.78	0.86	0.73	0.79
EPS Growth	6.83%	17.49%	-9.38%	17.81%	-7.17%	15.93%
Free Cash Flow	89.29	9.31	-62.75	-205.07	7.92	18.28
Free Cash Flow Per Share	0.53	0.05	-0.37	-1.23	0.05	0.14
Dividend Per Share	0.270	0.270	0.240	0.260	0.285	0.175
Dividend Growth	12.50%	12.50%	-7.69%	-8.77%	62.86%	-86.22%
Gross Margin	60.16%	58.19%	56.75%	59.34%	65.40%	60.90%
Operating Margin	23.18%	21.79%	22.08%	31.13%	34.97%	32.70%
Profit Margin	20.76%	20.17%	22.21%	30.77%	33.86%	34.77%
Free Cash Flow Margin	11.09%	1.24%	-10.71%	-44.13%	2.21%	6.38%
EBITDA	250.75	206.86	159.99	168.81	143.23	105.38
EBITDA Margin	31.13%	27.48%	27.31%	36.33%	39.96%	36.79%
D&A For EBITDA	64.05	42.79	30.65	24.17	17.88	11.71
EBIT	186.7	164.07	129.34	144.64	125.35	93.67
EBIT Margin	23.18%	21.79%	22.08%	31.13%	34.97%	32.70%
Effective Tax Rate	12.94%	12.51%	7.36%	9.79%	15.00%	13.74%

Source: S&P Capital IQ. Standard template. Financial Sources.